IP Library Granted Patent US 7,901,879
Granted Patent B2
US 7,901,879 · App. 10/434,769 · Granted Mar 8, 2011

Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases

Assignee: Agennix Incorporated
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,901,879
App. No.
10/434,769
Granted
Mar 8, 2011
Kind
B2
Abstract

The present invention relates to methods of treating a hyperproliferative disease by administering a composition of lactoferrin alone or in combination with standard anti-cancer therapies.

Claims (2)

1. A method of treating an established solid Renal cell carcinoma comprising the step of administering orally to a human subject a mature native human lactoferrin protein as a monotherapy in an amount sufficient to reduce the rate of growth or shrink the established solid Renal cell carcinoma in the human subject.

2. A method of treating an established solid Non-small cell lung cancer a comprising the step of administering orally to a human subject a mature native human lactoferrin protein as a monotherapy in an amount sufficient to reduce the rate of growth or shrink the established solid Non-small cell lung cancer in the human subject.

Assignments (2)
SECURITY AGREEMENT Recorded Mar 16, 2009
From: AGENNIX INCORPORATED
To: GPC BIOTECH AG
Reel/Frame 022399/0104 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2003
From: VARADHACHARY, ATUL; BARSKY, RICK; PERICLE, FEDERICA; PETRAK, KAREL; WANG, YENYUN
To: AGENNIX INCORPORATED
Reel/Frame 014533/0523 →
Continuity (4)
Provisional Application 60379442 · May 10, 2002
Provisional Application 60379441 · May 10, 2002
Provisional Application 60379474 · May 10, 2002
Related Publication 20040009895A1 · Jan 15, 2004